GTR Test Accession:
Help
GTR000502872.4
CAP
Last updated in GTR: 2018-09-24
View version history
GTR000502872.4, last updated: 2018-09-24
GTR000502872.3, last updated: 2017-08-07
GTR000502872.2, last updated: 2016-07-27
GTR000502872.1, last updated: 2014-05-02
Last annual review date for the lab: 2021-10-14
Past due
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment
Conditions (1):
Help
Thrombophilia due to activated protein C resistance
Genes (1):
Help
F5 (1q24.2)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: Gold nanoparticle probe technology
Target population: Help
Individuals exhibiting recurrent VTE (venous thromboembolism) especially DVT (deep vein …
Clinical validity:
Help
Up to 30% of patients presenting with deep vein thrombosis …
Clinical utility:
Help
Establish or confirm diagnosis;
Predictive risk information for patient and/or family members
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Amniocytes
- Amniotic fluid
- Buccal swab
- Chorionic villi
- Isolated DNA
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
LOINC codes:
Help
Lab contact:
Help
Contact Policy:
Help
Post-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
How to Order:
Help
1. Choose the desired test from the Test Directory.
2. Obtain information on the required specimen for the specific test from the Test Information page.
3. Fill out the necessary test requisition form and any other required forms from the Forms page.
4. Provide the required Billing information or make …
2. Obtain information on the required specimen for the specific test from the Test Information page.
3. Fill out the necessary test requisition form and any other required forms from the Forms page.
4. Provide the required Billing information or make …
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Test development:
Help
FDA-reviewed (has FDA test name)
Informed consent required:
Help
No
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Test Order Code,
Test strategy
Conditions
Help
Total conditions: 1
| Condition/Phenotype | Identifier |
|---|
Test Targets
Genes
Help
Total genes: 1
| Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
|---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Targeted variant analysis
Gold nanoparticle probe technology
Nanosphere Verigene System
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment
Clinical validity:
Help
Up to 30% of patients presenting with deep vein thrombosis (DVT) or pulmonary embolism (PE) have the mutation.
Clinical utility:
Help
Establish or confirm diagnosis
Predictive risk information for patient and/or family members
Predictive risk information for patient and/or family members
Target population:
Help
Individuals exhibiting recurrent VTE (venous thromboembolism) especially DVT (deep vein thrombosis) in the legs and upper extremities. Individuals at risk of pregnancy loss and complications such as preeclampsia, fetal growth retardation, and placental abruption. Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to activated protein C (APC) …
View more
Recommended fields not provided:
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
Confirmation is performed on a new blood specimen (if submitted) and a separate DNA preparation using the same methodology
Test Confirmation:
Help
Confirmation is performed on a new blood specimen (if submitted) and a separate DNA preparation using the same methodology
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Analytical sensitivity, specificity and accuracy greater than 99%; determined by in-house validations.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Assay limitations,
Description of internal test validation method,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.